Annual CFF
$2.01 M
-$51.07 M-96.21%
31 December 2023
Summary:
Atara Biotherapeutics annual cash flow from financing activities is currently $2.01 million, with the most recent change of -$51.07 million (-96.21%) on 31 December 2023. During the last 3 years, it has fallen by -$425.56 million (-99.53%). ATRA annual CFF is now -99.53% below its all-time high of $427.57 million, reached on 31 December 2020.ATRA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$35.79 M
+$36.12 M+11147.22%
30 September 2024
Summary:
Atara Biotherapeutics quarterly cash flow from financing activities is currently $35.79 million, with the most recent change of +$36.12 million (+11147.22%) on 30 September 2024. Over the past year, it has increased by +$36.00 million (+17308.17%). ATRA quarterly CFF is now -87.91% below its all-time high of $296.01 million, reached on 31 March 2018.ATRA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$61.12 M
+$36.00 M+143.31%
30 September 2024
Summary:
Atara Biotherapeutics TTM cash flow from financing activities is currently $61.12 million, with the most recent change of +$36.00 million (+143.31%) on 30 September 2024. Over the past year, it has increased by +$28.33 million (+86.42%). ATRA TTM CFF is now -85.70% below its all-time high of $427.57 million, reached on 31 December 2020.ATRA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.2% | +10000.0% | +86.4% |
| 3 y3 years | -99.5% | -24.1% | -73.6% |
| 5 y5 years | -99.4% | -75.5% | -61.2% |
ATRA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.5% | at low | -30.5% | >+9999.0% | -73.6% | +2940.9% |
| 5 y | 5 years | -99.5% | at low | -81.3% | >+9999.0% | -85.7% | +2940.9% |
| alltime | all time | -99.5% | +297.2% | -87.9% | +893.6% | -85.7% | >+9999.0% |
Atara Biotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $35.79 M(<-9900.0%) | $61.12 M(+143.3%) |
| June 2024 | - | -$324.00 K(-101.3%) | $25.12 M(-3.1%) |
| Mar 2024 | - | $24.14 M(+1496.6%) | $25.92 M(+1189.4%) |
| Dec 2023 | $2.01 M(-96.2%) | $1.51 M(-826.9%) | $2.01 M(-93.9%) |
| Sept 2023 | - | -$208.00 K(-144.2%) | $32.79 M(+0.0%) |
| June 2023 | - | $471.00 K(+100.4%) | $32.78 M(-2.0%) |
| Mar 2023 | - | $235.00 K(-99.3%) | $33.47 M(-37.0%) |
| Dec 2022 | $53.08 M(-48.9%) | $32.29 M(<-9900.0%) | $53.08 M(-26.5%) |
| Sept 2022 | - | -$214.00 K(-118.5%) | $72.26 M(-39.6%) |
| June 2022 | - | $1.16 M(-94.2%) | $119.61 M(-1.1%) |
| Mar 2022 | - | $19.85 M(-61.4%) | $120.90 M(+16.3%) |
| Dec 2021 | $103.94 M(-75.7%) | $51.47 M(+9.2%) | $103.94 M(-55.1%) |
| Sept 2021 | - | $47.14 M(+1826.3%) | $231.27 M(+6.3%) |
| June 2021 | - | $2.45 M(-15.4%) | $217.64 M(-46.5%) |
| Mar 2021 | - | $2.89 M(-98.4%) | $406.51 M(-4.9%) |
| Dec 2020 | $427.57 M(+126.5%) | $178.80 M(+433.6%) | $427.57 M(+49.4%) |
| Sept 2020 | - | $33.51 M(-82.5%) | $286.23 M(-28.2%) |
| June 2020 | - | $191.31 M(+698.6%) | $398.66 M(+85.7%) |
| Mar 2020 | - | $23.96 M(-36.0%) | $214.67 M(+13.7%) |
| Dec 2019 | $188.79 M(-47.2%) | $37.45 M(-74.3%) | $188.79 M(+20.0%) |
| Sept 2019 | - | $145.94 M(+1891.8%) | $157.36 M(+1342.7%) |
| June 2019 | - | $7.33 M(-480.4%) | $10.91 M(-81.7%) |
| Mar 2019 | - | -$1.93 M(-132.0%) | $59.60 M(-83.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $357.54 M(+1683.4%) | $6.02 M(-1269.1%) | $357.54 M(+1.5%) |
| Sept 2018 | - | -$515.00 K(-100.9%) | $352.21 M(-2.9%) |
| June 2018 | - | $56.02 M(-81.1%) | $362.60 M(+14.6%) |
| Mar 2018 | - | $296.01 M(>+9900.0%) | $316.38 M(+1478.1%) |
| Dec 2017 | $20.05 M(+3862.1%) | $698.00 K(-92.9%) | $20.05 M(+1.9%) |
| Sept 2017 | - | $9.87 M(+0.7%) | $19.68 M(+96.6%) |
| June 2017 | - | $9.81 M(-3108.0%) | $10.01 M(+4955.6%) |
| Mar 2017 | - | -$326.00 K(-198.5%) | $198.00 K(-60.9%) |
| Dec 2016 | $506.00 K(-99.8%) | $331.00 K(+66.3%) | $506.00 K(+40.6%) |
| Sept 2016 | - | $199.00 K(-3416.7%) | $360.00 K(-99.8%) |
| June 2016 | - | -$6000.00(-66.7%) | $194.22 M(+2.4%) |
| Mar 2016 | - | -$18.00 K(-109.7%) | $189.72 M(-26.8%) |
| Dec 2015 | $259.23 M(+268.9%) | $185.00 K(-99.9%) | $259.23 M(-18.3%) |
| Sept 2015 | - | $194.06 M(-4403.0%) | $317.13 M(+158.8%) |
| June 2015 | - | -$4.51 M(-106.5%) | $122.52 M(-3.0%) |
| Mar 2015 | - | $69.49 M(+19.6%) | $126.29 M(+79.7%) |
| Dec 2014 | $70.27 M(+31.7%) | $58.09 M(<-9900.0%) | $70.27 M(+38.9%) |
| Sept 2014 | - | -$548.00 K(-25.5%) | $50.60 M(-1.1%) |
| June 2014 | - | -$736.00 K(-105.5%) | $51.15 M(-4.2%) |
| Mar 2014 | - | $13.47 M(-64.9%) | $53.38 M(0.0%) |
| Dec 2013 | $53.38 M | $38.41 M(>+9900.0%) | $53.38 M(+256.7%) |
| Sept 2013 | - | $0.00(-100.0%) | $14.96 M(0.0%) |
| June 2013 | - | $1.49 M(-88.9%) | $14.96 M(+11.1%) |
| Mar 2013 | - | $13.47 M | $13.47 M |
FAQ
- What is Atara Biotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual CFF year-on-year change?
- What is Atara Biotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly CFF year-on-year change?
- What is Atara Biotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Atara Biotherapeutics?
- What is Atara Biotherapeutics TTM CFF year-on-year change?
What is Atara Biotherapeutics annual cash flow from financing activities?
The current annual CFF of ATRA is $2.01 M
What is the all time high annual CFF for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual cash flow from financing activities is $427.57 M
What is Atara Biotherapeutics annual CFF year-on-year change?
Over the past year, ATRA annual cash flow from financing activities has changed by -$51.07 M (-96.21%)
What is Atara Biotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of ATRA is $35.79 M
What is the all time high quarterly CFF for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly cash flow from financing activities is $296.01 M
What is Atara Biotherapeutics quarterly CFF year-on-year change?
Over the past year, ATRA quarterly cash flow from financing activities has changed by +$36.00 M (+17308.17%)
What is Atara Biotherapeutics TTM cash flow from financing activities?
The current TTM CFF of ATRA is $61.12 M
What is the all time high TTM CFF for Atara Biotherapeutics?
Atara Biotherapeutics all-time high TTM cash flow from financing activities is $427.57 M
What is Atara Biotherapeutics TTM CFF year-on-year change?
Over the past year, ATRA TTM cash flow from financing activities has changed by +$28.33 M (+86.42%)